Opertech Bio and AXXSense Enter Strategic Cooperation Agreement Leave a Comment / News / ASolia 10 October 2024 – 14:00 CEST Opertech Bio and AXXSense Enter Strategic Cooperation Agreement Read More »
Isogenica Ltd. and Axxam S.p.A. Announce Collaboration to Provide Unique VHH Antibody Discovery Solutions Leave a Comment / News / ASolia Example single news Isogenica Ltd. and Axxam S.p.A. Announce Collaboration to Provide Unique VHH Antibody Discovery Solutions Read More »
Axxam Awarded EcoVadis Silver Medal for Sustainability Performance Leave a Comment / News / ASolia Example single news Axxam Awarded EcoVadis Silver Medal for Sustainability Performance Read More »
Axxam enters CNS partnership with Lundbeck for Lead Identification Leave a Comment / News / ASolia Example single news Axxam enters CNS partnership with Lundbeck for Lead Identification Read More »
Momentum Biotechnologies and Axxam announce collaboration to provide unique drug discovery solutions Leave a Comment / News / ASolia Example single news Momentum Biotechnologies and Axxam announce collaboration to provide unique drug discovery solutions Read More »
Ciriaco Maraschiello joins Axxam as Chief Operating Officer Leave a Comment / News / ASolia 5 July 2023 Ciriaco Maraschiello joins Axxam as Chief Operating Officer Read More »
Uwe Gottschalk appointed as Board Observer Leave a Comment / News / ASolia 15 June 2023 Uwe Gottschalk appointed as Board Observer Read More »
Jörg Hüser joins Axxam as Chief Scientific Officer Leave a Comment / News / ASolia 1 June 2023 Jörg Hüser joins Axxam as Chief Scientific Officer Read More »
Axxam and Promega announce agreement to develop smart assays for drug discovery services Leave a Comment / News / ASolia 23 May 2023 Axxam and Promega announce agreement to develop smart assays for drug discovery services Read More »
Keensight Capital to acquire a majority stake in Axxam, a leading European partner research organization in life sciences Leave a Comment / News / ASolia 28 July 2022 Keensight Capital to acquire a majority stake in Axxam, a leading European partner research organization in life sciences Read More »
